227 related articles for article (PubMed ID: 2152301)
1. Detection of rheumatoid factors of different isotypes and of circulating immune complexes in patients with inflammatory bowel disease.
Procaccia S; Bianchi Porro G; Colucci A; Villa P; Blasio R; Ardizzone S; Bonacina CA; Zanussi C
Boll Ist Sieroter Milan; 1990 Jun; 69(2):413-21. PubMed ID: 2152301
[TBL] [Abstract][Full Text] [Related]
2. IgM, IgG and IgA rheumatoid factors and circulating immune complexes in patients with AIDS and AIDS-related complex with serological abnormalities.
Procaccia S; Lazzarin A; Colucci A; Gasparini A; Forcellini P; Lanzanova D; Foppa CU; Novati R; Zanussi C
Clin Exp Immunol; 1987 Feb; 67(2):236-44. PubMed ID: 3608224
[TBL] [Abstract][Full Text] [Related]
3. Measles IgM immunoreactivity in patients with inflammatory bowel disease.
Balzola FA; Khan K; Pera A; Bonino F; Pounder RE; Wakefield AJ
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):378-82. PubMed ID: 9789132
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
Mokrowiecka A; Gasiorowska A; Małecka-Panas E
Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
[TBL] [Abstract][Full Text] [Related]
5. Does IgA-alpha1 antitrypsin complex correlate with IgM, IgG and IgA rheumatoid factor in early rheumatoid arthritis?
Lacki JK; Hrycaj P; Klama K; Mackiewicz U; Mackiewicz SH; Muller W
Mater Med Pol; 1994; 26(3):97-100. PubMed ID: 7603085
[TBL] [Abstract][Full Text] [Related]
6. Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosis.
Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Yazawa N; Tamaki K
Br J Dermatol; 2004 Oct; 151(4):803-8. PubMed ID: 15491420
[TBL] [Abstract][Full Text] [Related]
7. [IgM, IgG and IgA rheumatoid factors in rheumatoid arthritis].
Naranjo Hernández A; Muniain Ezcurra MA; Vargas Lebrón MC; Rodríguez Barrera JM; Prieto Martínez J; Navarro Sarabia F
An Med Interna; 1989 Nov; 6(11):575-9. PubMed ID: 2562699
[TBL] [Abstract][Full Text] [Related]
8. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulins and IgG subclasses in patients with inflammatory bowel disease.
Gouni-Berthold I; Baumeister B; Berthold HK; Schmidt C
Hepatogastroenterology; 1999; 46(27):1720-3. PubMed ID: 10430330
[TBL] [Abstract][Full Text] [Related]
10. Rheumatoid factor isotypes in localized scleroderma.
Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K
Clin Exp Dermatol; 2005 Jul; 30(4):405-8. PubMed ID: 15953082
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulins (Ig) in circulating immune complexes (CIC) in cancer and inflammatory bowel disease (IBD).
Shafir M; Martinelli G; Bekesi JG; Jaramillo S; Heimann T; Aufses AH
Eur J Surg Oncol; 1986 Dec; 12(4):351-7. PubMed ID: 3780988
[TBL] [Abstract][Full Text] [Related]
12. Routine measurement of IgM, IgG, and IgA rheumatoid factors: high sensitivity, specificity, and predictive value for rheumatoid arthritis.
Swedler W; Wallman J; Froelich CJ; Teodorescu M
J Rheumatol; 1997 Jun; 24(6):1037-44. PubMed ID: 9195506
[TBL] [Abstract][Full Text] [Related]
13. IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease.
Shinzaki S; Iijima H; Nakagawa T; Egawa S; Nakajima S; Ishii S; Irie T; Kakiuchi Y; Nishida T; Yasumaru M; Kanto T; Tsujii M; Tsuji S; Mizushima T; Yoshihara H; Kondo A; Miyoshi E; Hayashi N
Am J Gastroenterol; 2008 May; 103(5):1173-81. PubMed ID: 18177457
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum anti-carbonic anhydrase II antibodies in patients with ulcerative colitis.
Andoh A; Fujiyama Y; Yoshioka U; Sasaki M; Araki Y; Tsujikawa T; Bamba T
Int J Mol Med; 2002 May; 9(5):499-502. PubMed ID: 11956656
[TBL] [Abstract][Full Text] [Related]
15. T-cell immunoregulation in patients with inflammatory bowel disease. II. Enhanced suppressor T-cell activity in ulcerative colitis.
Kramer JK; Depew WT; Szewczuk MR
J Clin Lab Immunol; 1988 Jan; 25(1):19-27. PubMed ID: 2968458
[TBL] [Abstract][Full Text] [Related]
16. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
[TBL] [Abstract][Full Text] [Related]
17. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
[TBL] [Abstract][Full Text] [Related]
18. 7S IgG rheumatoid factor and hidden 19S IgM rheumatoid factor in juvenile chronic arthritis.
Roizenblatt S; Goldenberg J; Gabriel A; Hilário MO; Atra E
Allergol Immunopathol (Madr); 1993; 21(5):197-200. PubMed ID: 8160565
[TBL] [Abstract][Full Text] [Related]
19. A polyclonal IgM-RF enzyme-linked immunosorbent assay for the detection of circulating immune complexes.
Bukh A; Thomsen BS; Kimose HH; Nielsen LR; Svehag SE; Møller NP
J Clin Lab Immunol; 1988 Aug; 26(4):195-200. PubMed ID: 3199429
[TBL] [Abstract][Full Text] [Related]
20. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K
Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
